Additionally, follow-up investigations have linked PPARγ nuclear condensates to a better prognosis in breast cancer patients, whereas patients with cytoplasmic condensates exhibit a poorer prognosis [144, 145]. The gene discussed is PPARG; the disease is breast cancer.